HomePress-release

Redding, California - May 11, 2023

Single-use Bioreactors Market to be Worth $10.3 Billion by 2030

Single-use Bioreactors Market by Product [Systems, Media Bags (2D, 3D), Filtration Assemblies], Type [Stirred-tank, Wave-induced], Cell [Mammalian, Bacterial, Yeast], Application [Commercial (Mab, Vaccine), Research], End User - Global Forecast to 2030

Meticulous Research^®—a leading global market research company, published a research report titled ‘Single-use Bioreactors Market by Product [Systems, Media Bags (2D, 3D), Filtration Assemblies], Type [Stirred-tank, Wave-induced], Cell [Mammalian, Bacterial, Yeast], Application [Commercial (Mab, Vaccine), Research], End User - Global Forecast to 2030.’

According to this latest publication from Meticulous Research^®, the single-use bioreactors market is projected to reach $10.3 billion by 2030, at a CAGR of 15.8%. The growing adoption of disposable technologies in the pharmaceutical and biotechnology industries, capacity expansions of biopharmaceutical plants, rising pharmaceutical R&D expenditures, the rising adoption of biosimilars, and the growing prevalence of chronic diseases are the factors driving the growth of this market.

Single-use Bioreactors Market: Future Outlook

The global single-use bioreactors market is segmented by Product {Single use Bioreactor Systems (Upto 10L, 11L-500L, 501L-1000L, and above 1001L), Media Bags (2D, 3D, and Linear), Filtration Assemblies, and Others}, Type (Stirred-Tank, Stirred-Tank, Wave-Induced, and Others), Cell Type (Mammalian Cells, Bacterial Cells, Yeast Cells, and Others), Application [Commercial Bioproduction (mAb Production, Vaccine Production, Therapeutic Protein Production, and Cell and Gene Therapy) Research Bioproduction], End User {Pharmaceutical and Biopharmaceutical Companies; Contract Research Organizations and Contract Development and Manufacturing Organizations (CDMO); and Academic and Research Institutes}, and Geography. The study also evaluates industry competitors and analyzes their market share at global and regional levels.

Based on product, the single-bioreactor market is segmented into single-use bioreactor systems, media bags, filtration assemblies, and other products. In 2023, the single-use bioreactor systems segment is expected to account for the largest share of the market. The large market share of this segment is attributed to its advantages like lesser cleaning requirements, smaller footprint, less capital investment, more flexibility, and reduced risk of cross-contamination and vendors’ focus on large-scale bio-manufacturing.

Based on type, in 2023, the stirred-tank bioreactors segment is expected to account for the largest share of the market. The large market share of this segment is attributed to its high preference for CHO cell lines & suspension culture and large volume bio-production and minimized challenges associated with traditional design.

Based on cell type, in 2023, the mammalian cells segment is expected to account for the largest share of the market. The large market share of this segment is attributed to the increasing focus on commercial & research bioproduction, like developing complex biomolecules such as monoclonal antibodies and therapeutic proteins, and increasing clinical research, which uses mammalian cells for the majority of experiments.

Based on application, in 2023, the commercial bio-production segment is expected to account for the largest share of the market. The large market share of this segment is attributed to the increasing number of chronic diseases in the geriatric population, the rising demand to produce biopharmaceuticals, and regulatory reforms favoring the adoption of biosimilars.

Based on end user, the contract development and manufacturing organizations (CDMOs) and contract research organizations (CROs) segment is projected to register the highest CAGR during the forecast period. The growth of this segment is driven by the outsourcing by the pharmaceutical and biopharmaceutical companies to CDMOs, key players’ preference for inorganic growth strategies, and expansion strategy by CDMOs.

Geographic Review

This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, Ireland, Denmark, Belgium, and the Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and the Rest of Asia-Pacific), Latin America, and the Middle East & Africa. In 2023, Europe is expected to account for the largest share of the single-use bioreactors market. The large share of this market is attributed to increasing sales of drugs, support from government and regulatory authorities to promote the use of biopharmaceuticals for various health indications, and various companies expanding their manufacturing capacities as well as their operations.

Key Players

The key players profiled in the single-use bioreactors market report are Merck KGaA (Germany), Danaher Corporation (U.S.), Sartorius AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Eppendorf AG (Germany), Solaris Biotechnology srl (Italy), Cellexus International Ltd. (U.K.) CESCO Bioengineering Co., Ltd. (Taiwan), PBS Biotech, Inc. (U.S.), Distek, Inc. (U.S.), and Infors AG (Switzerland).

Download Sample Report Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5005

Key questions answered in the report-

Which are the high-growth market segments in terms of type, cell type, application, end user, and regions/countries?
What was the historical market for single-use bioreactors across the globe?
What are the market forecasts and estimates for the period 2023–2030?
What are the major drivers, challenges, opportunities, and trends in the global market of single-use bioreactors?
Who are the major players in the global single-use bioreactors market?
What is the competitive landscape, and who are the market leaders in the global single-use bioreactors market?
What are the recent developments in the single-use bioreactors market?
What are the different strategies adopted by the major players in the single-use bioreactors market?
What are the geographical trends and high-growth regions/countries?

Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

3D Printing

5G Technology

Advanced Chemical & Materials

Agrochemicals

Algae Products

Alternative Proteins

Animal Health

Artificial Intelligence

Automotive Technologies

Big Data Analytics

Climate Technologies

Edible Insects

Electric Vehicle

Food & Agriculture Technologies

Hydrogen Technologies

Internet Of Things

In Vitro Diagnostics

Laboratory Instrumentation

Language Learning Technologies

Medical Technologies

Next Generation Technologies

Processing & Packaging Technologies

Robotics & Automation

Smart Technologies

Water & Wastewater Technologies

Miscellaneous / Others

Redding, California - May 11, 2023

Single-use Bioreactors Market to be Worth $10.3 Billion by 2030

Single-use Bioreactors Market by Product [Systems, Media Bags (2D, 3D), Filtration Assemblies], Type [Stirred-tank, Wave-induced], Cell [Mammalian, Bacterial, Yeast], Application [Commercial (Mab, Vaccine), Research], End User - Global Forecast to 2030

Recommended Readings

Advanced Chemical &
Materials

Food & Agriculture
Technologies

Next Generation
Technologies

Processing & Packaging
Technologies

Water & Wastewater
Technologies